DENVER--(BUSINESS WIRE)--Three renowned speakers will present the most innovative research, collaborations and partnerships within the bioscience industry today at the Rocky Mountain Life Science Investor and Partnering Conference (RMLIPC), Thursday, September 22, at the Brown Palace Hotel in Denver. The announcement is made by Holli Riebel (formerly Baumunk), President and CEO of the Colorado BioScience Association (CBSA), who says: "The conference will be attended by leaders of early-stage private and public life science, bioscience investors and strategic partners."
The RMLIPC is the region’s only bioscience conference of its kind. This year’s speakers will discuss new innovative business models to bring emerging technologies to market and develop partnerships for success. “The keynote presenters are crucial thought leaders shaping the future of the bioscience industry,” Riebel said.
The breakfast keynote on Thursday will feature Peter A. Gottlieb, MD, Professor of Pediatrics and Medicine at the University of Colorado Denver and Center Director at the Barbara Davis Center for Childhood Diabetes, and Dennis R. Roop, Ph.D., Director of The Charles C. Gates Center for Regenerative Medicine and Stem Cell Biology at the University of Colorado Anschutz Medical Campus. According to Riebel, the CBSA is honored to present these two thought leaders in the clinical world and the stem cell research arena. Drs. Gottlieb and Roop will share how they look at research philanthropy as a growing model for creating and sustaining university initiatives, including Centers of Excellence, that address critical research needs and potential commercializable opportunities.
The luncheon keynote will feature Roy Davis, President, Johnson & Johnson Corporate Development. Mr. Davis is a returning expert presenter at the conference and will share his presentation “Strategic Value Creation: A Corporate Investor’s View,” including his vision for new partnering research and development strategies and expert insight into current issues affecting the biotechnology industry.
The RMLIPC will bring a national focus to the Rocky Mountain region—drawing together 200 bioscience community leaders to shape the future of the industry.
About The Rocky Mountain Life Science Investor and Partnering Conference
The second Rocky Mountain Life Science Investor & Partnering Conference is building upon the success of the inaugural conference in 2009. More than thirty of the industry’s leading investors and strategic partners will attend presentations by the region’s most innovative life science companies September 22 at the Brown Palace Hotel, Denver. The RMLIPC includes companies, investors and representatives from Arizona, Colorado, Montana, New Mexico, Oklahoma, Utah and Canada. The conference will open with a reception at the Colorado Governor’s Mansion September 21st and follow Thursday with a full day of company presentations and keynote speakers. For more information and registration details, visit www.RockyMtnBioInvest.com.
Link to the news release listing the participating investors/partners: http://www.businesswire.com/news/home/20110907005526/en/2011-Rocky-Mountain-Life-Science-Investor-Partnering
Link to the news release listing the companies selected to present at the RMLIPC: http://www.businesswire.com/news/home/20110809005872/en/Regional-Companies-Selected-Present-2011-Rocky-Mountain
About Colorado BioScience Association
The CBSA is a not-for-profit corporation providing services and support for Colorado's growing biosciences industry. With more than 350 members, CBSA actively works to promote the growth of the industry by working for a better business environment, grow the state's biotech workforce, fight for policies that support a strong bioscience industry in the state and speak with a single voice on behalf of the industry. For more information, visit www.cobioscience.com.